Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

Healthcare Biotechnology
"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Adverse Events
View:
Post by NYYANKEE on Nov 18, 2015 9:12am

Adverse Events

Not feeling good about those adverse events. However after BCG failures it's the only way to go!
Comment by ragingbull1327 on Nov 18, 2015 9:15am
I'm pretty sure Valstar is the one shaking right now.   ;)
Comment by 13PunterDog on Nov 18, 2015 9:32am
I think Telesta was trying to let it be known that it won't hurt a patients chance of survival if they delay removal of bladder for MCNA treatment after BCG failure. They nailed that with Cohen's I( as I recall ) presentation. This is a major issue with the FDA and also with our Japanese friends. JMHO
Comment by 13PunterDog on Nov 18, 2015 9:36am
FDA lady rehashing Telesta's presentation on the trial. Total waste of time
Comment by ragingbull1327 on Nov 18, 2015 9:44am
Wasting time?  The FDA?   Unheard of.....lol
TELESTA THERAPEUTICS INC